Tag Archives: drugs

Device Meet Drug: Integrating Combination Products Into Your Portfolio

By Anna Julia Hummel, Dr. Tido Eger
No Comments

Combination products are a major growth area for life science companies and in the future, many companies have or will have combination products in their portfolio. Combination products are made of drug, device and/or biologics constituent parts. Each constituent part has its own set of regulations to which it must adhere. For example, even if…

Continue reading